Browsing Centre for Oral Immunobiology and Regenerative Medicine by Author "Giovannoni, G"
Now showing items 1-2 of 2
-
A cell-based assay for the detection of neutralizing antibodies against alemtuzumab.
Ali, L; Saxena, G; Jones, M; Leisegang, GR; Gammon, L; Gnanapavan, S; Giovannoni, G; Schmierer, K; Baker, D; Kang, AS (2020-02-25)Aim: The humanized anti-CD52 monoclonal antibody alemtuzumab depletes lymphocytes and is currently used to treat relapsing multiple sclerosis. During treatment, anti-alemtuzumab antibodies may develop and reduce effective ... -
COVID-19 vaccine-readiness for anti-CD20-depleting therapy in autoimmune diseases
Baker, D; Roberts, CAK; Pryce, G; Kang, AS; Marta, M; Reyes, S; Schmierer, K; Giovannoni, G; Amor, S (2020-08-01)